- Home
- OXSQ vs LFCR Comparison
OXSQ vs LFCR Comparison
Compare OXSQ & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXSQ
- LFCR
- Stock Information
- Founded
- OXSQ 2003
- LFCR 1986
- Country
- OXSQ United States
- LFCR United States
- Employees
- OXSQ N/A
- LFCR N/A
- Industry
- OXSQ Blank Checks
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- OXSQ Finance
- LFCR Health Care
- Exchange
- OXSQ Nasdaq
- LFCR Nasdaq
- Market Cap
- OXSQ 185.5M
- LFCR 164.3M
- IPO Year
- OXSQ N/A
- LFCR N/A
- Fundamental
- Price
- OXSQ $2.60
- LFCR $7.47
- Analyst Decision
- OXSQ
- LFCR Buy
- Analyst Count
- OXSQ 0
- LFCR 2
- Target Price
- OXSQ N/A
- LFCR $10.00
- AVG Volume (30 Days)
- OXSQ 409.6K
- LFCR 195.3K
- Earning Date
- OXSQ 11-05-2024
- LFCR 10-04-2024
- Dividend Yield
- OXSQ 16.16%
- LFCR N/A
- EPS Growth
- OXSQ N/A
- LFCR N/A
- EPS
- OXSQ N/A
- LFCR 0.17
- Revenue
- OXSQ $44,787,853.00
- LFCR $128,443,999.00
- Revenue This Year
- OXSQ N/A
- LFCR $2.23
- Revenue Next Year
- OXSQ N/A
- LFCR $8.40
- P/E Ratio
- OXSQ N/A
- LFCR $45.01
- Revenue Growth
- OXSQ N/A
- LFCR 23.42
- 52 Week Low
- OXSQ $2.59
- LFCR $3.68
- 52 Week High
- OXSQ $3.29
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- OXSQ 31.03
- LFCR 56.70
- Support Level
- OXSQ $2.63
- LFCR $7.19
- Resistance Level
- OXSQ $2.66
- LFCR $7.88
- Average True Range (ATR)
- OXSQ 0.03
- LFCR 0.39
- MACD
- OXSQ 0.00
- LFCR -0.04
- Stochastic Oscillator
- OXSQ 7.69
- LFCR 55.91
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.